The Patent Finder

Terms ending in 2037

BioLineRx Ltd.

Every in-force patent on BioLineRx Ltd.'s record whose computed term ends in 2037, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 10,682,390Compositions and Methods for Treating Cancer
In force
 · High confidence
Biokine Therapeutics Ltd.In forceHigh confidence
US 10,786,547Compositions, Articles of Manufacture and Methods for Treating Cancer
In force
 · High confidence
Biolinerx Ltd.In forceHigh confidence
US 11,534,478Compositions and Methods for Treating Cancer
In force
 · High confidence
Biokine Therapeutics Ltd.In forceHigh confidence
US 11,554,159Compositions and Methods for Treating Cancer
In force
 · High confidence
Biokine Therapeutics Ltd.In forceHigh confidence
US 11,559,562Compositions and Methods for Treating Cancer
In force
 · High confidence
Biokine Therapeutics Ltd.In forceHigh confidence
US 11,596,666Compositions and Methods for Treating Cancer
In force
 · High confidence
Biokine Therapeutics Ltd.In forceHigh confidence
US 11,607,444Compositions and Methods for Treating Cancer
In force
 · High confidence
Biokine Therapeutics Ltd.In forceHigh confidence
US 11,612,638Compositions and Methods for Treating Cancer
In force
 · High confidence
Biokine Therapeutics Ltd.In forceHigh confidence
US 11,638,742Compositions and Methods for Treating Cancer
In force
 · High confidence
Biokine Therapeutics Ltd.In forceHigh confidence
US 11,638,743Compositions and Methods for Treating Cancer
In force
 · High confidence
Biokine Therapeutics Ltd.In forceHigh confidence
4 more term ends in 2037 · Pro
10 of 14 patents shown. Soonest term end first, then patent number.
Pro members see all 14.
Upgrade to Pro
2 of these are in force and held by BioLineRx Ltd..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited